79 related articles for article (PubMed ID: 18598812)
1. [Germinal loss-of-function mutations in the spred1 gene cause conditions similar to neurofibromatosis type 1].
Dereure O
Ann Dermatol Venereol; 2008; 135(6-7):529-30. PubMed ID: 18598812
[No Abstract] [Full Text] [Related]
2. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.
Brems H; Chmara M; Sahbatou M; Denayer E; Taniguchi K; Kato R; Somers R; Messiaen L; De Schepper S; Fryns JP; Cools J; Marynen P; Thomas G; Yoshimura A; Legius E
Nat Genet; 2007 Sep; 39(9):1120-6. PubMed ID: 17704776
[TBL] [Abstract][Full Text] [Related]
3. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
[TBL] [Abstract][Full Text] [Related]
4. SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype.
Spurlock G; Bennett E; Chuzhanova N; Thomas N; Jim HP; Side L; Davies S; Haan E; Kerr B; Huson SM; Upadhyaya M
J Med Genet; 2009 Jul; 46(7):431-7. PubMed ID: 19443465
[TBL] [Abstract][Full Text] [Related]
5. Expanding the phenotype of a neurofibromatosis type 1-like syndrome: a patient with a SPRED1 mutation and orbital manifestations.
Lane KA; Anninger WV; Katowitz JA
Ophthalmic Plast Reconstr Surg; 2009; 25(5):399-401. PubMed ID: 19966658
[TBL] [Abstract][Full Text] [Related]
6. Identification of five novel SPRED1 germline mutations in Legius syndrome.
Laycock-van Spyk S; Jim HP; Thomas L; Spurlock G; Fares L; Palmer-Smith S; Kini U; Saggar A; Patton M; Mautner V; Pilz DT; Upadhyaya M
Clin Genet; 2011 Jul; 80(1):93-6. PubMed ID: 21649642
[No Abstract] [Full Text] [Related]
7. Pigmentary findings in neurofibromatosis type 1-like syndrome (Legius syndrome): potential diagnostic dilemmas.
Stevenson D; Viskochil D
JAMA; 2009 Nov; 302(19):2150-1. PubMed ID: 19920242
[No Abstract] [Full Text] [Related]
8. Novel human pathological mutations. Gene symbol: SPRED1. Disease: Legius syndrome.
Jim HP; Upadhyaya M
Hum Genet; 2010 Jan; 127(1):112. PubMed ID: 20108422
[No Abstract] [Full Text] [Related]
9. Mosaicism for a SPRED1 deletion revealed in a patient with clinically suspected mosaic neurofibromatosis.
Jobling RK; Lara-Corrales I; Hsiao MC; Shugar A; Hedges S; Messiaen L; Kannu P
Br J Dermatol; 2017 Apr; 176(4):1077-1078. PubMed ID: 27423141
[No Abstract] [Full Text] [Related]
10. SPRED 1 mutations in a neurofibromatosis clinic.
Muram-Zborovski TM; Stevenson DA; Viskochil DH; Dries DC; Wilson AR; Rong Mao
J Child Neurol; 2010 Oct; 25(10):1203-9. PubMed ID: 20179001
[TBL] [Abstract][Full Text] [Related]
11. Novel human pathological mutations. Gene symbol: SPRED1. Disease: Legius syndrome.
Jim HP; Upadhyaya M
Hum Genet; 2010 Jan; 127(1):111. PubMed ID: 20108421
[No Abstract] [Full Text] [Related]
12. Novel human pathological mutations. Gene symbol: SPRED1. Disease: Legius syndrome.
Jim HP; Upadhyaya M
Hum Genet; 2010 Jan; 127(1):111-2. PubMed ID: 20108386
[No Abstract] [Full Text] [Related]
13. Novel human pathological mutations. Gene symbol: SPRED1. Disease: Legius syndrome.
Jim HP; Upadhyaya M
Hum Genet; 2010 Jan; 127(1):111. PubMed ID: 20108385
[No Abstract] [Full Text] [Related]
14. Novel human pathological mutations. Gene symbol: SPRED1. Disease: Legius syndrome.
Jim HP; Upadhyaya M
Hum Genet; 2010 Jan; 127(1):111. PubMed ID: 20108420
[No Abstract] [Full Text] [Related]
15. Error in a study of the clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Legius E
JAMA; 2010 Jun; 303(24):2476-7. PubMed ID: 20571013
[No Abstract] [Full Text] [Related]
16. A cost savings approach to SPRED1 mutational analysis in individuals at risk for neurofibromatosis type 1.
Muram TM; Stevenson DA; Watts-Justice S; Viskochil DH; Carey JC; Mao R; Jackson B
Am J Med Genet A; 2013 Mar; 161A(3):467-72. PubMed ID: 23401230
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis type 1.
McLaughlin ME; Jacks T
Methods Mol Biol; 2003; 222():223-37. PubMed ID: 12710690
[No Abstract] [Full Text] [Related]
18. A severe form of Noonan syndrome and autosomal dominant café-au-lait spots - evidence for different genetic origins.
Nyström AM; Ekvall S; Strömberg B; Holmström G; Thuresson AC; Annerén G; Bondeson ML
Acta Paediatr; 2009 Apr; 98(4):693-8. PubMed ID: 19120036
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis Type 1 Molecular Diagnosis: The RNA Point of View.
Pasmant E; Vidaud D
EBioMedicine; 2016 May; 7():21-2. PubMed ID: 27322453
[No Abstract] [Full Text] [Related]
20. Germline mutations in the CDKN1B gene encoding p27 Kip1 are a rare cause of multiple endocrine neoplasia type 1.
Owens M; Stals K; Ellard S; Vaidya B
Clin Endocrinol (Oxf); 2009 Mar; 70(3):499-500. PubMed ID: 18673462
[No Abstract] [Full Text] [Related]
[Next] [New Search]
